J07 Vaccines
ATC class of level 2 – therapeutic subgroup
This page lists the patient medication information or the product monograph for 119 drugs in this drug class and its subclasses.
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|
| Td Adsorbed PM (J07AM51 Tetanus toxoid, comb. with diphtheria toxoid) |
– |
| Td Polio Adsorbed (J07CA01 Diphtheria-poliomyelitis-tetanus) |
– |
| Tripacel PM (J07AJ52 Pertussis, purified antigen, comb. with toxoids) |
– |
| Tripacel Hybrid (J07AJ52 Pertussis, purified antigen, comb. with toxoids) |
– |
| Twinrix PM (J07BC20 Combinations) |
– |
| Typherix PM (J07AP03 Typhoid, purified polysaccharide antigen) |
– |
| Typhim VI (J07AP03 Typhoid, purified polysaccharide antigen) |
– |
| Vaqta PM (J07BC02 Hepatitis A, inactivated, whole virus) |
– |
| Varilrix PM (J07BK01 Varicella, live attenuated) |
– |
| Varivax III PM (J07BK01 Varicella, live attenuated) |
– |
| Vaxchora PM (J07AE02 Cholera, live attenuated) |
– |
| Vaxigrip PM (J07BB02 Influenza, inactivated, split virus or surface antigen) |
– |
| Vaxneuvance PM (J07AL02 Pneumococcus, purified polysacc.antigen conjugated) |
– |
| Vaxzevria (Astrazeneca Canada, PM 00062879) (J07BN02 COVID-19, viral vector, non-replicating) |
– |
| Vaxzevria (Astrazeneca Canada, PM 00068758) (J07BN02 COVID-19, viral vector, non-replicating) |
– |
| Vimkunya PM (J07BP02 Chikungunya, virus-like particles) |
prescription (Rx) |
| Vivaxim PM (J07CA10 Typhoid-hepatitis a) |
– |
| Vivotif PM (J07AP01 Typhoid, oral, live attenuated) |
– |
| Yf-Vax PM (J07BL01 Yellow fever, live attenuated) |
– |
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J07
Ask your doctor or pharmacist for advice.
